Reata Pharmaceuticals

14 email addresses found for reatapharma.com
{first}.{l}@reatapharma.com
14 email addresses
http://benzinga.com/pressreleases/16/10/g8537164/reata-enrolls-first-patient-in-phase-3-catalyst-trial-of-bardoxolone-me May 5, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-closing-of/464882 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-pricing-of/464426 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-proposed/464219 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-s-bardoxolone-methyl/463868 September 9, 2017
http://firstwordpharma.com/node/1504861 October 10, 2017
http://formkit.com/wire/reata-pharmaceuticals-inc-announces-second-quarter-2016-financial-and-operating-results August 8, 2016
http://globenewswire.ca/news-release/2017/09/13/1120523/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma.html October 10, 2017
http://globenewswire.com/news-release/2017/06/01/1005786/0/en/reata-pharmaceuticals-inc-announces-positive-data-from-part-one-of-moxie-trial-of-omaveloxolone-for-friedreich-s-ataxia.html October 10, 2017
http://marketwatch.com/story/reata-announces-the-initiation-of-phase-2-studies-examining-rta-408-for-the-treatment-of-friedreichs-ataxia-and-mitochondrial-myopathies-2014-09-30 September 9, 2017
http://marketwired.com/press-release/reata-announces-initial-phase-2-pulmonary-arterial-hypertension-data-bardoxolone-methyl-2067451.htm September 9, 2017
http://marketwired.com/press-release/reata-announces-initiation-phase-2-studies-examining-rta-408-treatment-friedreichs-ataxia-1952199.htm September 9, 2017
http://marketwired.com/press-release/reata-enrolls-first-patient-moxie-study-phase-2-3-study-examining-rta-408-friedreichs-1987066.htm August 8, 2017
http://marketwired.com/press-release/reata-enrolls-first-patient-primrose-study-phase-2-study-examining-rta-408-breast-cancer-1932722.htm September 9, 2017
http://marketwired.com/press-release/reata-pharmaceuticals-receives-orphan-drug-designation-bardoxolone-methyl-from-us-fda-2008458.htm September 9, 2017
http://mitoaction.org/blog/2016-mito-town-meeting March 3, 2016
http://nasdaq.com/press-release/reata-announces-first-patient-enrolled-in-phase-3-cardinal-trial-of-bardoxolone-methyl-in-the-20170807-01298 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-pricing-of-class-a-common-stock-public-offering-20170726-01938 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-proposed-public-offering-of-class-a-common-stock-20170725-01395 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-bardoxolone-methyl-for-the-treatmen-20170710-00272 August 8, 2017
http://nasdaq.com/press-release/reatas-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-i-20170724-00299 August 8, 2017
http://news.learnatchina.com/2016052616327.html May 5, 2016
http://news.learnatchina.com/tag/cbt/page/2 May 5, 2016
http://news.learnatchina.com/tag/growth May 5, 2016
http://news.learnatchina.com/tag/mobile-learning May 5, 2016
http://reatapharma.com/contact-us January 1, 2016
http://reatapharma.com/legal-message January 1, 2016
http://reatapharma.com/reata-announces-initial-phase-2-pulmonary-arterial-hypertension-data-for-bardoxolone-methyl-and-planned-initiation-of-phase-3-study January 1, 2016
http://reatapharma.com/reata-enrolls-first-patient-with-pulmonary-hypertension-associated-with-interstitial-lung-disease-in-lariat-a-phase-2-study-examining-bardoxolone-methyl-for-the-treatment-of-patients-with-pulmonary-h January 1, 2016
http://reatapharma.com/reata-to-present-initial-phase-2-data-on-bardoxolone-methyl-a-novel-experimental-therapy-for-pulmonary-hypertension-used-in-patients-on-stable-background-pah-therapy January 1, 2016
http://benzinga.com/pressreleases/16/10/g8537164/reata-enrolls-first-patient-in-phase-3-catalyst-trial-of-bardoxolone-me May 5, 2017
http://biospace.com/article/releases/reata-pharmaceuticals-inc-s-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-in-ongoing-phase-ii-portion-of October 10, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-closing-of/464882 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-pricing-of/464426 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-proposed/464219 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-s-bardoxolone-methyl/463868 September 9, 2017
http://cnbc.com/2016/05/25/globe-newswire-reata-pharmaceuticals-inc-announces-pricing-of-initial-public-offering.html February 2, 2018
http://cnbc.com/2016/08/11/globe-newswire-reata-pharmaceuticals-inc-announces-second-quarter-2016-financial-and-operating-results.html March 3, 2018
http://cnbc.com/2017/07/25/globe-newswire-reata-pharmaceuticals-inc-announces-proposed-public-offering-of-class-a-common-stock.html November 11, 2017
http://cnbc.com/2017/07/26/globe-newswire-reata-pharmaceuticals-inc-announces-pricing-of-class-a-common-stock-public-offering.html November 11, 2017
http://cnbc.com/2017/08/01/globe-newswire-reata-pharmaceuticals-inc-announces-closing-of-class-a-common-stock-public-offering-and-full-exercise-of-underwritersa.html November 11, 2017
http://crweworld.com/article/news-provided-by-globenewswire/137598/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma October 10, 2017
http://euroinvestor.com/news/2017/09/13/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/13672330 November 11, 2017
http://firstwordpharma.com/node/1504861 October 10, 2017
http://formkit.com/wire/reata-pharmaceuticals-inc-announces-second-quarter-2016-financial-and-operating-results November 11, 2016
http://globenewswire.ca/news-release/2017/09/13/1120523/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma.html October 10, 2017
http://globenewswire.com/news-release/2017/06/01/1005786/0/en/reata-pharmaceuticals-inc-announces-positive-data-from-part-one-of-moxie-trial-of-omaveloxolone-for-friedreich-s-ataxia.html October 10, 2017
http://health.einnews.com/pr_news/403741941/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma October 10, 2017
http://hunter.io/companies/reatapharma.com December 12, 2017
http://investors.reatapharma.com/phoenix.zhtml October 10, 2016
http://money.ca/news/category/pharmaceuticals-and-biotech January 1, 2018
http://nasdaq.com/press-release/reata-announces-first-patient-enrolled-in-phase-3-cardinal-trial-of-bardoxolone-methyl-in-the-20170807-01298 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-pricing-of-class-a-common-stock-public-offering-20170726-01938 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-proposed-public-offering-of-class-a-common-stock-20170725-01395 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-bardoxolone-methyl-for-the-treatmen-20170710-00272 August 8, 2017
http://nasdaq.com/press-release/reatas-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-i-20170724-00299 August 8, 2017
http://news.learnatchina.com/2016052616327.html February 2, 2017
http://pm360online.com/category/nasdaq/nasdaq-nephrology-market-news November 11, 2017
http://reatapharma.com/contact-us January 1, 2017
http://thenewsreports.com/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/32035/staff October 10, 2017
4 more results for reatapharma.com. Sign up or log in to access the full results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 800,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about reatapharma.com

Language of the website: English